Motif ID: Pparg_Rxrg
Z-value: 1.191


Transcription factors associated with Pparg_Rxrg:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Pparg | ENSMUSG00000000440.6 | Pparg |
Rxrg | ENSMUSG00000015843.4 | Rxrg |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Rxrg | mm10_v2_chr1_+_167598384_167598411 | -0.22 | 1.6e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.1 | 3.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) terpenoid catabolic process(GO:0016115) primary alcohol catabolic process(GO:0034310) |
0.9 | 3.4 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.6 | 3.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 2.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.5 | 4.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 0.5 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
0.4 | 1.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.4 | 1.3 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.4 | 2.5 | GO:2000483 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 2.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 2.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 1.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.9 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.3 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 2.0 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.3 | 2.8 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.3 | 0.8 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.3 | 1.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.3 | 1.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 1.1 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 1.3 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.2 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 2.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.2 | 0.7 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.2 | 1.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 2.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.6 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.2 | 2.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 1.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.6 | GO:0061324 | mammary placode formation(GO:0060596) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 1.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.9 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 0.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.7 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.2 | 0.9 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.2 | 0.5 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 1.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 0.8 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.2 | 0.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.9 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 1.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.7 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.1 | 0.7 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.4 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.1 | 0.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.5 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.1 | 1.3 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 0.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 2.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 0.3 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 1.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.2 | GO:0032229 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 1.0 | GO:1904668 | mitotic spindle midzone assembly(GO:0051256) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 1.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.2 | GO:0010666 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.3 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.1 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 1.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.3 | GO:0038095 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Fc-epsilon receptor signaling pathway(GO:0038095) Kit signaling pathway(GO:0038109) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 1.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.7 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) phosphate ion transmembrane transport(GO:0035435) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 3.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 1.6 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.3 | GO:1990743 | protein sialylation(GO:1990743) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.6 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 1.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.7 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.2 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.4 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 2.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.7 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 1.7 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0001798 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type I hypersensitivity(GO:0001812) type II hypersensitivity(GO:0002445) positive regulation of hypersensitivity(GO:0002885) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 3.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.7 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 1.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.5 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 2.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.0 | 0.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.0 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) negative regulation of female gonad development(GO:2000195) |
0.0 | 0.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.2 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
0.0 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0072720 | response to sorbitol(GO:0072708) response to dithiothreitol(GO:0072720) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 1.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.4 | GO:1900194 | receptor guanylyl cyclase signaling pathway(GO:0007168) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) myotome development(GO:0061055) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.0 | 0.2 | GO:2000189 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.4 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 1.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.1 | GO:0048296 | negative regulation of isotype switching(GO:0045829) isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.0 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.2 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 1.8 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0009446 | putrescine metabolic process(GO:0009445) putrescine biosynthetic process(GO:0009446) |
0.0 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.2 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.4 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 2.5 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.1 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.0 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.1 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
0.0 | 0.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.0 | 0.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.7 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.1 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.0 | 0.1 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0061153 | hair follicle placode formation(GO:0060789) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.2 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
0.0 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 1.4 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:0050821 | protein stabilization(GO:0050821) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.7 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.0 | 0.4 | GO:0051693 | actin filament capping(GO:0051693) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 1.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 1.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.4 | GO:0070985 | TFIIK complex(GO:0070985) |
0.1 | 1.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 3.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.9 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.2 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
0.1 | 1.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 2.5 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 2.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 1.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 6.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 1.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.7 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.3 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 1.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:1990761 | dendritic spine neck(GO:0044326) growth cone lamellipodium(GO:1990761) |
0.0 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 1.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 1.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 2.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 2.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.5 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.6 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 1.2 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 2.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 1.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.2 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 4.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 4.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 1.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.4 | 3.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.3 | 1.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 1.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 0.9 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 0.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.7 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.2 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 1.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 1.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 1.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 2.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 1.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 0.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.2 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.5 | GO:0005118 | sevenless binding(GO:0005118) |
0.2 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.2 | 0.5 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.2 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 1.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 0.6 | GO:0043546 | molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 4.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 3.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.5 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.1 | 0.5 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.3 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.1 | 1.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.3 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.1 | 2.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 1.7 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 1.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.7 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 1.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 2.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 3.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.4 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.5 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.9 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 3.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 5.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0004096 | aminoacylase activity(GO:0004046) catalase activity(GO:0004096) |
0.1 | 1.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.2 | GO:0070573 | tripeptidyl-peptidase activity(GO:0008240) metallodipeptidase activity(GO:0070573) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 2.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 2.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 1.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.1 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.8 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 1.0 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 1.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 5.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.0 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 2.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.5 | ST_STAT3_PATHWAY | STAT3 Pathway |
0.1 | 0.3 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.1 | 0.3 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
0.1 | 0.2 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.0 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
0.1 | 0.7 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.5 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.4 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.0 | 0.7 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.0 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.9 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.0 | 1.4 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.5 | PID_ATR_PATHWAY | ATR signaling pathway |
0.0 | 4.4 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.7 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
0.0 | 0.1 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.2 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.2 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.0 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.5 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 0.7 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.2 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.1 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.0 | 0.9 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.9 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.4 | PID_ARF6_PATHWAY | Arf6 signaling events |
0.0 | 0.2 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
0.0 | 2.0 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.4 | PID_FGF_PATHWAY | FGF signaling pathway |
0.0 | 0.1 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.9 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID_FOXO_PATHWAY | FoxO family signaling |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.1 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 3.5 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 1.9 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.8 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.2 | 1.0 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 6.3 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.9 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.8 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.6 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.8 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.3 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.5 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 3.7 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.1 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.2 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.8 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.5 | REACTOME_PYRIMIDINE_CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.6 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.8 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.3 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.4 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.7 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.4 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.9 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.0 | 1.7 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.9 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.3 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.0 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.0 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.8 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 1.1 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.5 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.8 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.7 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.6 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.4 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.4 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.6 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.6 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.5 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.4 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 1.3 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.1 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.6 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 1.9 | REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.4 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.2 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.7 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.7 | REACTOME_MRNA_3_END_PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 1.3 | REACTOME_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.7 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.2 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.1 | REACTOME_GAP_JUNCTION_TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.1 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |